{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert and Charles Tapley Hoyt",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/73ec5665b99a7a4b84edd84bbd46b34fac335358/external/mesh-names.belns"
    },
    "path": "receptors/dani2007.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, and postsynaptic and nonsynaptic nAChRs mediate excitation as well as activity-dependent modulation of circuits and intracellular enzymatic processes. ",
      "key": "bcb3f6ae04ddb7416328e18831fabc6f",
      "line": 62,
      "relation": "increases",
      "source": 60,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Activation of presynaptic nAChRs increases the release of many different neurotransmitters (1, 2, 4, 5, 40, 41, 77–83).",
      "key": "7956453d420bd4ce8a29d8bd0a0c0035",
      "line": 188,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Presynaptic and preterminal nAChRs increase the release of neurotransmitters in the hippocampus, particularly the main neurotransmitters, GABA and glutamate (41, 78, 81, 97).",
      "key": "6959d25e9c27b29720be7abbf3337c46",
      "line": 265,
      "relation": "increases",
      "source": 60,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Post-Synaptic Density": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, and postsynaptic and nonsynaptic nAChRs mediate excitation as well as activity-dependent modulation of circuits and intracellular enzymatic processes. ",
      "key": "23f8c540829af432948b08e8024a76b4",
      "line": 66,
      "relation": "regulates",
      "source": 60,
      "target": 43
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Axons": true,
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Furthermore, by directly exciting or by shunting the progress of an action potential at a bifurcation, axonal or dendritic nAChRs alter the spread of neuronal excitation.",
      "key": "8668820b81edaa7212c82006836b7938",
      "line": 257,
      "relation": "regulates",
      "source": 60,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Post-Synaptic Density": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, and postsynaptic and nonsynaptic nAChRs mediate excitation as well as activity-dependent modulation of circuits and intracellular enzymatic processes. ",
      "key": "f300b7d7a9ace549e86564894b99091d",
      "line": 67,
      "relation": "regulates",
      "source": 60,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "e7740825376ff091b441bbd6d220d8d6",
      "line": 74,
      "relation": "association",
      "source": 60,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic stimulation enhances glutamate release on multiple timescales, extending from seconds to a few minutes (81), and contributes to the induction of synaptic plasticity (4, 13, 14, 16, 88).",
      "key": "5516110fe9c5e7122e6c58fc0715f526",
      "line": 231,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 41
    },
    {
      "annotations": {
        "Cell": {
          "glutamatergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic receptors also modulate glutamatergic synaptic plasticity.",
      "key": "bfcab3d518a51aa1c36975f3d2ef3e38",
      "line": 291,
      "relation": "association",
      "source": 60,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "ce496ce14819379f62aa35fd245af10c",
      "line": 75,
      "relation": "association",
      "source": 60,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "fdb9f3ba0efca14d285528a0a4510bd7",
      "line": 76,
      "relation": "association",
      "source": 60,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "78f2bf9ba97be0ba0da050acc471d2cd",
      "line": 77,
      "relation": "association",
      "source": 60,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "d39138198168b395e900a8c9652a3a78",
      "line": 78,
      "relation": "association",
      "source": 60,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "4866c0f804c8b6dd92a6d31bb517130f",
      "line": 83,
      "relation": "association",
      "source": 60,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "804092a9e9fb5fd887b900dae22406e9",
      "line": 384,
      "relation": "association",
      "source": 60,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "9ae1cf5c5cc8d14fc8bb5a1f127b04a4",
      "line": 84,
      "relation": "association",
      "source": 60,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "e890f20c54609bf8be2f8f4076996e34",
      "line": 383,
      "relation": "association",
      "source": 60,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "b1ecd4bc412a11a011b89c420b412726",
      "line": 85,
      "relation": "association",
      "source": 60,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "819f467a37bbcdb685ddae21dcafde81",
      "line": 372,
      "relation": "negativeCorrelation",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "c119fcae8e698ef591298a0c886f4d60",
      "line": 377,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "e8802662b9a0681cbedc28589c2b59c7",
      "line": 86,
      "relation": "association",
      "source": 60,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "d283e04e2077f04ef49cd998b92eaeae",
      "line": 369,
      "relation": "negativeCorrelation",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "3a8efb702026b6e3ce66b3aee114a13e",
      "line": 374,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 72
    },
    {
      "annotations": {
        "Cell": {
          "cholinergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "As AD worsens, cholinergic neurons are progressively lost and the number of nAChRs declines, particularly in the hippocampus and cortex (140, 158).",
      "key": "91d763023f1958c34cc082ab9bd23754",
      "line": 434,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "4e13b1a42c4b96c9be55f762dc485988",
      "line": 87,
      "relation": "association",
      "source": 60,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Mammalian nAChRs are cation selective, being permeable to small monovalent and divalent cations.",
      "key": "fd11dd26033326e71973e950d62e6ce3",
      "line": 92,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Mammalian nAChRs are cation selective, being permeable to small monovalent and divalent cations.",
      "key": "368f0ab4b95835f87862200acee381eb",
      "line": 93,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Mammalian nAChRs are cation selective, being permeable to small monovalent and divalent cations.",
      "key": "7759856aa672c5775d2de958a39d51e4",
      "line": 94,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Mammalian nAChRs are cation selective, being permeable to small monovalent and divalent cations.",
      "key": "3d200af802b95f14c8a3f74d2f4979f1",
      "line": 95,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic receptor activity causes depolarization, and the divalent cation perme- ability plays an important physiological role by supplying ionic signals, including calcium (39–41).",
      "key": "429a317a4382b80064ea71aa1e5cafec",
      "line": 102,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In addition, nAChR activity produces a depolarization that activates voltage-gated calcium channels in the presynaptic terminal (87). ",
      "key": "016aea98229f694a4a04c0a28cca22f6",
      "line": 221,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dendrites": true,
          "Neocortex": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Activation of nAChRs on distal apical dendrites depolarizes the cell and promotes action potential ﬁring",
      "key": "449f5346c4c243b3d3be37233bc8ed17",
      "line": 304,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic receptors mediate a small direct calcium inﬂux (42–44, 85).",
      "key": "b403f8b67505abb3c25512b90531f0b5",
      "line": 210,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic stimulation enhances glutamate release on multiple timescales, extending from seconds to a few minutes (81), and contributes to the induction of synaptic plasticity (4, 13, 14, 16, 88).",
      "key": "0ee8382a7659111efb18293d1cfec120",
      "line": 230,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Presynaptic and preterminal nAChRs increase the release of neurotransmitters in the hippocampus, particularly the main neurotransmitters, GABA and glutamate (41, 78, 81, 97).",
      "key": "7d11c0f712e7cce0f073f7b2e2185e97",
      "line": 267,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Presynaptic and preterminal nAChRs increase the release of neurotransmitters in the hippocampus, particularly the main neurotransmitters, GABA and glutamate (41, 78, 81, 97).",
      "key": "2ed1d8b2f1ae732d1df58393cb82c7c1",
      "line": 266,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA3 Region, Hippocampal": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In the rat CA3 region, spontaneous activation of GABA A receptors produces giant depolarizing potentials, whose frequency is controlled by α7∗ and non-α7 nAChRs.",
      "key": "b98eab032a5c356b04f0ba8902888470",
      "line": 283,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 60,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Activation and desensitization of nAChRs by bath-applied nicotine also increases LTD induced by a stimulus train",
      "key": "8798351a6e4ec34df29a899697368b2c",
      "line": 298,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dendrites": true,
          "Neocortex": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Activation of nAChRs on distal apical dendrites depolarizes the cell and promotes action potential ﬁring",
      "key": "2415bf42434545f4c0749c770a588d4a",
      "line": 305,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 40
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Acting through these excitatory and inhibitory inputs and nAChRs located on the DA neurons, nicotinic receptors inﬂuence the ﬁring modes and ﬁring frequency of DA neurons (119, 121).",
      "key": "8c5c9c0c6b7896a7bd5046bcd1dbe51b",
      "line": 314,
      "relation": "association",
      "source": 60,
      "target": 40
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The nicotine initially activates nAChRs on DA neurons, causing an increase in burst ﬁring and overall ﬁring rate (88, 121, 123, 124, 134).",
      "key": "5dfc735876c912203ce9d7841811e88e",
      "line": 333,
      "relation": "increases",
      "source": 60,
      "target": 40
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Acting through these excitatory and inhibitory inputs and nAChRs located on the DA neurons, nicotinic receptors inﬂuence the ﬁring modes and ﬁring frequency of DA neurons (119, 121).",
      "key": "cf8a22e616c52cf27d885fae25424af7",
      "line": 315,
      "relation": "association",
      "source": 60,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "acf5510f464b9d5732d1c3e4208f6d8b",
      "line": 370,
      "relation": "negativeCorrelation",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "fa7f0e235ea6ce0ea8a7402e91f7960b",
      "line": 375,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "e3a48d432065ef5e6189168e1b9e8875",
      "line": 371,
      "relation": "negativeCorrelation",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "6332b2f6aff563b8c0dd0420a1494966",
      "line": 376,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "98c94e45f45e96a6e402b2063bc0c5ad",
      "line": 373,
      "relation": "negativeCorrelation",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "0ca9e2041b6ab9507ca5c04d347bf644",
      "line": 378,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "5df7be3226ff57d35a783f3eec2569a2",
      "line": 385,
      "relation": "association",
      "source": 60,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "578b91f932e59c3dd3392c6b4e58c9b4",
      "line": 386,
      "relation": "association",
      "source": 60,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "048705f7a112033f78c60c2afd8a9c77",
      "line": 387,
      "relation": "association",
      "source": 60,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": " Moreover, although nicotine increases wakefulness in wild-type mice, it does not affect β2−/− mice. Overall, stimulation of nAChRs promotes arousal and REM sleep.",
      "key": "443c089f032e4b4a22b2621a17c0a811",
      "line": 499,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": " Moreover, although nicotine increases wakefulness in wild-type mice, it does not affect β2−/− mice. Overall, stimulation of nAChRs promotes arousal and REM sleep.",
      "key": "a741d8faa2964b64321f1e389e9507bd",
      "line": 500,
      "relation": "increases",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "cc150b6183d9fb5f0b18430ef5cc5572",
      "line": 74,
      "relation": "association",
      "source": 41,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "glutamatergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic receptors also modulate glutamatergic synaptic plasticity.",
      "key": "ff203f00ebf5fbd567fd473a6a28c96f",
      "line": 291,
      "relation": "association",
      "source": 41,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "6d051f4ad4f09e485f7d839c5480b324",
      "line": 75,
      "relation": "association",
      "source": 81,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "ca4a7e6fd98b0b1b9038ad50b0782613",
      "line": 76,
      "relation": "association",
      "source": 47,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "8e4a55f6ff8ffb90f2a16fe301242f99",
      "line": 77,
      "relation": "association",
      "source": 48,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "By modulating activity-dependent events, nAChRs participate in fundamental aspects of synaptic plasticity that are involved in attention, learning, memory, and development (3, 12–16).",
      "key": "a20c38df9bf8bd1cec05f1828fff2d3c",
      "line": 78,
      "relation": "association",
      "source": 32,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "db56e53ef61fec5669cac9ea03427b86",
      "line": 83,
      "relation": "association",
      "source": 84,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "d596d8ed4f598763d55e80661ab2ea72",
      "line": 384,
      "relation": "association",
      "source": 84,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "04ccec17c3bc3b28d359363ccec327f1",
      "line": 84,
      "relation": "association",
      "source": 83,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "b6781d8a1f9429abad858eb6aced352e",
      "line": 383,
      "relation": "association",
      "source": 83,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "5ae35d68f6c6bc1e5bcb58fbdd75aa3c",
      "line": 85,
      "relation": "association",
      "source": 73,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "69b32c00c035ad6f4536e566a1d2f7da",
      "line": 372,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 73,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "5d826a9dc42103d9a10c3b61dc64c5b4",
      "line": 377,
      "relation": "negativeCorrelation",
      "source": 73,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "cd69256d59a28a2d79f9b3a87551ae68",
      "line": 86,
      "relation": "association",
      "source": 72,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "0bd6f09211511a82ee1dda9ee4ef7b0a",
      "line": 369,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 72,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "8fdbfa3b526223456f149a993ebd6c2a",
      "line": 374,
      "relation": "negativeCorrelation",
      "source": 72,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "cholinergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "As AD worsens, cholinergic neurons are progressively lost and the number of nAChRs declines, particularly in the hippocampus and cortex (140, 158).",
      "key": "0b770fc01ce4c0a8edf67b743027a7ed",
      "line": 434,
      "relation": "negativeCorrelation",
      "source": 72,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "cholinergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most well-appreciated neuronal loss, however, is in the cholinergic system (155, 156), particularly the basal forebrain cholinergic system comprised of the medial septal nucleus, the horizontal and vertical diagonal bands of Broca, and the nucleus basalis of Meynert (157).",
      "key": "4c2a444a453bc13c1313fa56ec079c87",
      "line": 425,
      "relation": "positiveCorrelation",
      "source": 72,
      "target": 36
    },
    {
      "annotations": {
        "Cell": {
          "cholinergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "As AD worsens, cholinergic neurons are progressively lost and the number of nAChRs declines, particularly in the hippocampus and cortex (140, 158).",
      "key": "3073b577d36858ba64ee56c2681d4751",
      "line": 433,
      "relation": "positiveCorrelation",
      "source": 72,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Although Aβ peptides negatively alter the cholinergic system at multiple sites, including ACh synthesis, ACh release, and muscarinic receptors (157), the discovery that Aβ1−42 binds to α7 nAChRs with high afﬁnity suggested the potential for a causal role of nAChRs in AD (159, 160).",
      "key": "d1734dabe5491474013ceee46a870cae",
      "line": 461,
      "relation": "association",
      "source": 72,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Decline, disruption, or alterations of nicotinic cholinergic mechanisms have been implicated in various dysfunctions, such as schizophrenia, epilepsy, autism, Alzheimer’s disease (AD), and addiction (17–23).",
      "key": "73c51a4c54b24f0805b593d164fc4581",
      "line": 87,
      "relation": "association",
      "source": 75,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In addition, nAChR activity produces a depolarization that activates voltage-gated calcium channels in the presynaptic terminal (87). ",
      "key": "7c9b2408e3f6bae6697bb038320ebe5c",
      "line": 222,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 35,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Similarly, replacement of the α7 leucine at the synaptic, extracellular end (position 254 or 255) of the pore by threonine dramatically reduced the calcium permeability of the α7 receptors.",
      "key": "6c44cfffe67239bc05bc3b19a8607daa",
      "line": 107,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 67,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Similarly, replacement of the α7 leucine at the synaptic, extracellular end (position 254 or 255) of the pore by threonine dramatically reduced the calcium permeability of the α7 receptors.",
      "key": "cfdc72597356b03abf36af07a6022dda",
      "line": 108,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 67,
      "target": 6
    },
    {
      "key": "a0f3e37e90f7acb47e741cb78a040df2",
      "relation": "hasVariant",
      "source": 65,
      "target": 67
    },
    {
      "key": "f1e8dacca58fbff7769b12f55d4272da",
      "relation": "hasVariant",
      "source": 65,
      "target": 68
    },
    {
      "key": "5eac22c1e343ba4d39620e26e8d52bc5",
      "relation": "hasVariant",
      "source": 65,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In some cases, the highly calcium-permeable α7-containing (α7∗) nAChRs mediate the increased release of neurotransmitter, but in other cases different nAChR subtypes are involved.",
      "key": "bef5b76fcab049b914bd84b2af806fa6",
      "line": 236,
      "relation": "increases",
      "source": 65,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Preterminal nAChRs located before the presynaptic terminal bouton indirectly affect neurotransmitter release by activating voltage-gated channels and, potentially, initiating action potentials (78, 91, 93).",
      "key": "d0640c5e00ae4f01559fde38e22a134e",
      "line": 243,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 65,
      "target": 50
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Simultaneously, nicotine activates presynaptic α7∗ nAChRs, boosting glutamatergic synaptic transmission onto DA neurons (23, 88, 123, 134).",
      "key": "b407905c2d77ed8e956d92e77bc41932",
      "line": 343,
      "relation": "increases",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 45
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Postsynaptic β2∗ nAChRs initially depolarize DA neurons, causing them to ﬁre action potentials while presynaptic α7∗ nAChRs boost glutamate release. ",
      "key": "75da95b1f9000b834b0619130f207fc7",
      "line": 354,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 65,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "key": "06da478aea7ffae7be02dc65ef4e2ac9",
      "relation": "partOf",
      "source": 65,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "f23fea510b3ae32136d9b92d04b62af4",
      "line": 466,
      "relation": "association",
      "source": 65,
      "target": 24
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "479ac4afa1848a45b062aa0d81f9cbed",
      "line": 469,
      "relation": "positiveCorrelation",
      "source": 65,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "b9b7f4c3f34788e161febf0e4d97977e",
      "line": 470,
      "relation": "positiveCorrelation",
      "source": 65,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This calcium inﬂux can trigger calcium-induced calcium release from intracellular stores (86).",
      "key": "7697389e09872fd70d7baa274cf5d244",
      "line": 215,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "cytosol",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Similarly, replacement of the α7 leucine at the synaptic, extracellular end (position 254 or 255) of the pore by threonine dramatically reduced the calcium permeability of the α7 receptors.",
      "key": "42185c0219c1369b2b568b004b22a032",
      "line": 109,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 68,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Similarly, replacement of the α7 leucine at the synaptic, extracellular end (position 254 or 255) of the pore by threonine dramatically reduced the calcium permeability of the α7 receptors.",
      "key": "5e107971079d70d0a0bb4551d2c142a3",
      "line": 110,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 68,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Unlike many neurotransmitter signals that are shaped by pumps that return the transmitter to the intracellular space, the spread of ACh from the release site is determined by diffusion and by acetylcholinesterase (AChE) hydrolysis of ACh.",
      "key": "b1dd2109f85e4b431dd38fc3831206a5",
      "line": 115,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "directlyIncreases",
      "source": 62,
      "subject": {
        "effect": {
          "name": "pep",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Another important aspect of this diffusive ACh signal is that its eventual hydrolysis creates choline, which also activates and desensitizes nAChRs in a subtype-selective manner (54, 55).",
      "key": "24d18a29588b8d38819012740c490638",
      "line": 129,
      "relation": "directlyIncreases",
      "source": 62,
      "subject": {
        "effect": {
          "name": "pep",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Unlike many neurotransmitter signals that are shaped by pumps that return the transmitter to the intracellular space, the spread of ACh from the release site is determined by diffusion and by acetylcholinesterase (AChE) hydrolysis of ACh.",
      "key": "420d404d856fe4c0112afa28fd1e4e22",
      "line": 117,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The α7 nAChR has a relatively low afﬁnity for ACh activation, with an effective dose for half-activation at approximately 200 μM ACh.",
      "key": "beed1a5ddb8b7231e5e5550a001a5903",
      "line": 136,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 65
    },
    {
      "key": "c7239eead0fe281b06c4c6158ad42dac",
      "relation": "partOf",
      "source": 14,
      "target": 54
    },
    {
      "key": "afcf75fd38d320f7162ca608a8da0f5a",
      "relation": "partOf",
      "source": 14,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In most cases, the exogenously applied ACh caused action potential ﬁring by the GABA neuron that consequently regulated the activity of nearby pyramidal neurons (100, 103).",
      "key": "9f118682bade4b93517905aef5a7cb0e",
      "line": 274,
      "relation": "increases",
      "source": 14,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Cholinergic volume transmission enables ACh to diffuse and to act at lower concentrations some distance away from the release site.",
      "key": "91844cefb0fe8d13e31d0df3e2d5e76c",
      "line": 122,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 44,
      "target": 14
    },
    {
      "key": "910137185781b8cf4f826758c1e645c0",
      "relation": "hasReactant",
      "source": 85,
      "target": 14
    },
    {
      "key": "722e8216f02de5c1edb057229df512b9",
      "relation": "hasProduct",
      "source": 85,
      "target": 13
    },
    {
      "key": "0173da3b51c157a893bb1ad6660364c9",
      "relation": "hasProduct",
      "source": 85,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Another important aspect of this diffusive ACh signal is that its eventual hydrolysis creates choline, which also activates and desensitizes nAChRs in a subtype-selective manner (54, 55).",
      "key": "a5f8ab443ba3265b7f17076ba2fc7d28",
      "line": 130,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 15,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "For example, ivermectin increases the apparent ACh afﬁnity, the slope of the dose-response curve, and the amplitude of nAChR responses (68).",
      "key": "572c153fa73aa13e07b35b039b928ea6",
      "line": 141,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "target": 60
    },
    {
      "key": "3f55de490171110d13918f3e3cf25e12",
      "relation": "partOf",
      "source": 19,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Ivermectin is an example of a positive allosteric effector that modiﬁes the pharmacological profile of the α7 nAChR.",
      "key": "08c82fedd90a2c2b8851981a410f60a5",
      "line": 146,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 19,
      "target": 65
    },
    {
      "key": "2b655c8c99456ef10feddf7161f4d6ad",
      "relation": "partOf",
      "source": 19,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Dimethylphenylpiperazidium (DMPP) normally is a partial agonist at this receptor subtype, but it becomes almost a full agonist following ivermectin exposure (68).",
      "key": "1f942554e40a3a2dd4339c00227d63bd",
      "line": 151,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 52,
      "target": 65
    },
    {
      "key": "27673c773701408a4909551e2217f81e",
      "relation": "partOf",
      "source": 0,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "5-Hydroxy-indol (5-HI) allosterically increases the α7 ACh-induced responses without modifying the response time course or sensitivity to the agonist (69).",
      "key": "060fa07ba749c0235d6d463fd52d7283",
      "line": 156,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 53,
      "target": 65
    },
    {
      "key": "c0b29885c1cfc418dfb7377a9eb9cce0",
      "relation": "partOf",
      "source": 2,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Another allosteric effector, 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596), dramatically modiﬁes the response time course, ampliude of the current, and agonist sensitivity of the rat and human α7 nAChRs (70).",
      "key": "88fc3930440eb7ebe3442b5e4317198a",
      "line": 161,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 1,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Dephosphorylation of the α7 receptor by genistein causes a signiﬁcant increase of ACh-evoked responses without modifying the response time course or ACh sensitivity (71, 72).",
      "key": "dfa0d38b78b0167645b0be91c8ae4e04",
      "line": 166,
      "relation": "decreases",
      "source": 18,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Results show that genistein does not alter the surface expression of nAChRs, but rather it modiﬁes nAChRs in the cell membrane (71).",
      "key": "461ac615cc3101e7b45bc6fe43c321db",
      "line": 172,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "cell surface",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 18,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cell Membrane": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Results show that genistein does not alter the surface expression of nAChRs, but rather it modiﬁes nAChRs in the cell membrane (71).",
      "key": "9d6e3dfeb116531d845cd8d783740001",
      "line": 174,
      "relation": "regulates",
      "source": 18,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Dephosphorylation of the α7 receptor by genistein causes a signiﬁcant increase of ACh-evoked responses without modifying the response time course or ACh sensitivity (71, 72).",
      "key": "2a145926d3f14a25854459a448e3ae8f",
      "line": 167,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 66,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cell Membrane": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Furthermore, Src-family kinases (SFKs) directly phosphorylate the cytoplasmic loop of α7 nAChRs in the plasma membrane.",
      "key": "d94af891b267cfecfba4d0c1da901253",
      "line": 181,
      "relation": "increases",
      "source": 61,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "7c1013b6a1414418fdb6c9b185db1faf",
      "line": 194,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "d0598832429da34c6cac939dc04e173f",
      "line": 195,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "93d3f132104190f62c3bcb583362292b",
      "line": 196,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "e9d42a1087925c2e80ebe1421a4fc665",
      "line": 197,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "9d5277ebd0171823c4722bdbc7693076",
      "line": 198,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "6269becc242379a2f432b0f920824643",
      "line": 199,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In general, nicotinic agonists improve certain forms of memory, and nicotinic antagonists and cholinergic lesions impair memory (5, 141–145).",
      "key": "a5ac1d7dc163cdec0784342d99d2bce8",
      "line": 392,
      "relation": "increases",
      "source": 10,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In animal studies, acute and chronic nicotine administration improves working memory, and nicotinic agonists were found to improve learning and memory in humans and nonhuman primates (145).",
      "key": "e77335db0fd6bb52c69c075072f358f6",
      "line": 412,
      "relation": "increases",
      "source": 10,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In animal studies, acute and chronic nicotine administration improves working memory, and nicotinic agonists were found to improve learning and memory in humans and nonhuman primates (145).",
      "key": "3241f3d0429292a0336b011e7935dbd0",
      "line": 411,
      "relation": "increases",
      "source": 10,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "During attention tasks, the nicotinic antagonist, mecamylamine, impaired accuracy or reaction time (151, 152) and nicotinic agonists improved accuracy (153). ",
      "key": "e5ec84fa3ed5daeae41706c7757e1d79",
      "line": 419,
      "relation": "increases",
      "source": 10,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Consistent with these treatments, nicotinic agents improve cognitive deﬁcits of AD patients (20, 158).",
      "key": "010baf12c15506587b01be608c774939",
      "line": 451,
      "relation": "increases",
      "source": 10,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "glutamatergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": " The combination of enhanced glutamatergic release and strong postsynaptic response produces LTP of the glutamatergic afferents.",
      "key": "e42bace2c5bdcd8b43473b4924b7553c",
      "line": 362,
      "relation": "increases",
      "source": 9,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "dce282b6db8c34a3f5dbae81a864e256",
      "line": 200,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 11,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "b5af5c17d6579b25521461d3017f4af7",
      "line": 201,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 11,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "3d7431144755cd3a94a105c7db4c3409",
      "line": 202,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 11,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "cbea0ceb1cb7288404890e2d131f6060",
      "line": 203,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 11,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "25d1ca0c06ea22a4b80b0ed5260060b1",
      "line": 204,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 11,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Exogenously applied nicotinic agonists enhance and nicotinic antagonists often diminish the release of ACh, dopamine (DA), norepinephrine, and serotonin, as well as glutamate and GABA.",
      "key": "89d164ddb1c95b26d128585a64528945",
      "line": 205,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 11,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In general, nicotinic agonists improve certain forms of memory, and nicotinic antagonists and cholinergic lesions impair memory (5, 141–145).",
      "key": "3cd8943a21c54f6178e2ba0534807771",
      "line": 393,
      "relation": "decreases",
      "source": 11,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic stimulation enhances glutamate release on multiple timescales, extending from seconds to a few minutes (81), and contributes to the induction of synaptic plasticity (4, 13, 14, 16, 88).",
      "key": "df8596276cb8694b8f9498db03ed5fb5",
      "line": 228,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Activation and desensitization of nAChRs by bath-applied nicotine also increases LTD induced by a stimulus train",
      "key": "267c692dd7eb568a870379b34db2ca22",
      "line": 297,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The nicotine initially activates nAChRs on DA neurons, causing an increase in burst ﬁring and overall ﬁring rate (88, 121, 123, 124, 134).",
      "key": "1da085fa55ef27e2055fc7b56f393e3f",
      "line": 332,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotine decreases tonic DA release in the striatum that is evoked by single action potentials (127), and nicotine also alters the frequency dependence of DA release that is electrically evoked by stimulus trains (130, 131).",
      "key": "8ed4a25fe00f2d2671ac0b1a700b4e9a",
      "line": 324,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 20,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Simultaneously, nicotine activates presynaptic α7∗ nAChRs, boosting glutamatergic synaptic transmission onto DA neurons (23, 88, 123, 134).",
      "key": "2f51be840f32728b2edb5ad6a631aad7",
      "line": 340,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In animal studies, acute and chronic nicotine administration improves working memory, and nicotinic agonists were found to improve learning and memory in humans and nonhuman primates (145).",
      "key": "2e57d8a82e4833afc25fb48085ec5618",
      "line": 410,
      "relation": "increases",
      "source": 20,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": " Moreover, although nicotine increases wakefulness in wild-type mice, it does not affect β2−/− mice. Overall, stimulation of nAChRs promotes arousal and REM sleep.",
      "key": "eaca8f176f6fa387883a22a58b0ac17c",
      "line": 496,
      "relation": "increases",
      "source": 20,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This effect of preterminal nAChRs is inhibited by tetrodotoxin, which blocks sodium channels and, thus, prevents the regenerative voltage-dependent activation of calcium channels in the presynaptic bouton.",
      "key": "db2a06603a80505aa02708ef0031efa6",
      "line": 249,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 23,
      "target": 50
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Acting through these excitatory and inhibitory inputs and nAChRs located on the DA neurons, nicotinic receptors inﬂuence the ﬁring modes and ﬁring frequency of DA neurons (119, 121).",
      "key": "c510480a16cd8e43363cc4047591aad2",
      "line": 314,
      "relation": "association",
      "source": 40,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA3 Region, Hippocampal": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "In the rat CA3 region, spontaneous activation of GABA A receptors produces giant depolarizing potentials, whose frequency is controlled by α7∗ and non-α7 nAChRs.",
      "key": "fad986ab1b3c363617d732625e13ee34",
      "line": 282,
      "relation": "increases",
      "source": 49,
      "subject": {
        "modifier": "Activity"
      },
      "target": 35
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Acting through these excitatory and inhibitory inputs and nAChRs located on the DA neurons, nicotinic receptors inﬂuence the ﬁring modes and ﬁring frequency of DA neurons (119, 121).",
      "key": "29341514196749843099b5533136babf",
      "line": 315,
      "relation": "association",
      "source": 39,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotine decreases tonic DA release in the striatum that is evoked by single action potentials (127), and nicotine also alters the frequency dependence of DA release that is electrically evoked by stimulus trains (130, 131).",
      "key": "df8a205822e1e8222e5de4fb9a05b5d1",
      "line": 323,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 28,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Post-Synaptic Density": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Postsynaptic β2∗ nAChRs initially depolarize DA neurons, causing them to ﬁre action potentials while presynaptic α7∗ nAChRs boost glutamate release. ",
      "key": "9da3cfc186bd8f5ae05e99f9ec7c87bc",
      "line": 351,
      "relation": "increases",
      "source": 69,
      "subject": {
        "modifier": "Activity"
      },
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": " Moreover, although nicotine increases wakefulness in wild-type mice, it does not affect β2−/− mice. Overall, stimulation of nAChRs promotes arousal and REM sleep.",
      "key": "8f8733853f10347946f9c6cc1caa3a42",
      "line": 497,
      "relation": "increases",
      "source": 69,
      "target": 30
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Post-Synaptic Density": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Postsynaptic β2∗ nAChRs initially depolarize DA neurons, causing them to ﬁre action potentials while presynaptic α7∗ nAChRs boost glutamate release. ",
      "key": "ecd2f8914f37a11d6cc8d6b4e4d1a18a",
      "line": 352,
      "relation": "increases",
      "source": 31,
      "target": 40
    },
    {
      "annotations": {
        "Cell": {
          "glutamatergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": " The combination of enhanced glutamatergic release and strong postsynaptic response produces LTP of the glutamatergic afferents.",
      "key": "e4d8326b3609d6e3501a8a1c8a15727e",
      "line": 363,
      "relation": "increases",
      "source": 31,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "6503f994697189fdde380b244a903fc7",
      "line": 370,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "b8d44a363a374c4ab5827d42a14533f4",
      "line": 375,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "613169deec71947524f2b27955fb4fb1",
      "line": 371,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 76,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "1393f226a12faf074818119a95ebeef4",
      "line": 376,
      "relation": "negativeCorrelation",
      "source": 76,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "c44415625164ff28a645230aaf831bdb",
      "line": 373,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 78,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Nicotinic mechanisms contribute to cognitive function, and the decline of nicotinic mechanisms or loss of nAChRs has been observed in AD, dementia with Lewy bodies, Down syndrome, autism, and Parkinson’s disease (20, 140).",
      "key": "9c6d20a9a5efef9a75ebfcbde4b3160e",
      "line": 378,
      "relation": "negativeCorrelation",
      "source": 78,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "fdd963c7ced1fe8a8594f67fcbc834ee",
      "line": 385,
      "relation": "association",
      "source": 42,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "c0abe035d95650b021cf3bb0854dee18",
      "line": 386,
      "relation": "association",
      "source": 79,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Genetic evidence has linked nicotinic receptors to epilepsy and schizophrenia, and studies with mutant mice have implicated nAChRs in pain mechanisms, anxiety, and depression.",
      "key": "c171d78271208cbfe8acd5b5d82befbf",
      "line": 387,
      "relation": "association",
      "source": 82,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Amygdala": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "For example, local infusion of the α7 antagonist, methyllycaconitine (MLA), or the β2∗ antagonist, dihydro-β-erythroidine (DHβE), into the basolateral amygdala, the ventral hippocampus, or the dorsal hippocampus impairs the working memory of rats seeking food reward within a 16-arm radial maze (146–148).",
      "key": "1ee230fde3b9a4d1f23f64382f33f6ca",
      "line": 400,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 27,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Amygdala": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "For example, local infusion of the α7 antagonist, methyllycaconitine (MLA), or the β2∗ antagonist, dihydro-β-erythroidine (DHβE), into the basolateral amygdala, the ventral hippocampus, or the dorsal hippocampus impairs the working memory of rats seeking food reward within a 16-arm radial maze (146–148).",
      "key": "d080b18626da48303e5f0d13a873185c",
      "line": 401,
      "relation": "decreases",
      "source": 27,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Amygdala": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "For example, local infusion of the α7 antagonist, methyllycaconitine (MLA), or the β2∗ antagonist, dihydro-β-erythroidine (DHβE), into the basolateral amygdala, the ventral hippocampus, or the dorsal hippocampus impairs the working memory of rats seeking food reward within a 16-arm radial maze (146–148).",
      "key": "13801ea9ecfc6253dfb2a9cda2cc8ca0",
      "line": 402,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Amygdala": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "For example, local infusion of the α7 antagonist, methyllycaconitine (MLA), or the β2∗ antagonist, dihydro-β-erythroidine (DHβE), into the basolateral amygdala, the ventral hippocampus, or the dorsal hippocampus impairs the working memory of rats seeking food reward within a 16-arm radial maze (146–148).",
      "key": "6c3776c4322fececa336a6a75282ec45",
      "line": 403,
      "relation": "decreases",
      "source": 7,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "During attention tasks, the nicotinic antagonist, mecamylamine, impaired accuracy or reaction time (151, 152) and nicotinic agonists improved accuracy (153). ",
      "key": "62214d348c59c9a2ff924fd91945a4c3",
      "line": 417,
      "relation": "isA",
      "source": 12,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "During attention tasks, the nicotinic antagonist, mecamylamine, impaired accuracy or reaction time (151, 152) and nicotinic agonists improved accuracy (153). ",
      "key": "673a03ce1447d045e6cc4c040c0d6fe9",
      "line": 418,
      "relation": "decreases",
      "source": 12,
      "target": 81
    },
    {
      "annotations": {
        "Cell": {
          "cholinergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most well-appreciated neuronal loss, however, is in the cholinergic system (155, 156), particularly the basal forebrain cholinergic system comprised of the medial septal nucleus, the horizontal and vertical diagonal bands of Broca, and the nucleus basalis of Meynert (157).",
      "key": "ec9e71e320c4e575e1db05c984428794",
      "line": 425,
      "relation": "positiveCorrelation",
      "source": 36,
      "target": 72
    },
    {
      "annotations": {
        "Cell": {
          "cholinergic neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "As AD worsens, cholinergic neurons are progressively lost and the number of nAChRs declines, particularly in the hippocampus and cortex (140, 158).",
      "key": "d26d31dbdb5dd036ab0ec7f4c837b01f",
      "line": 433,
      "relation": "positiveCorrelation",
      "source": 36,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most commonly prescribed treatments for AD are acetylcholinesterase inhibitors, which decrease the hydrolysis rate of ACh and, thereby, enhance cholinergic signaling. One such drug, galantamine (Reminyl\u0002), also potentiates nAChRs (66).",
      "key": "ad8ae90a5894bf1a9cec5dc646a46505",
      "line": 441,
      "relation": "decreases",
      "source": 3,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most commonly prescribed treatments for AD are acetylcholinesterase inhibitors, which decrease the hydrolysis rate of ACh and, thereby, enhance cholinergic signaling. One such drug, galantamine (Reminyl\u0002), also potentiates nAChRs (66).",
      "key": "236b7588a99e78548fe76e80f0e1babd",
      "line": 442,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most commonly prescribed treatments for AD are acetylcholinesterase inhibitors, which decrease the hydrolysis rate of ACh and, thereby, enhance cholinergic signaling. One such drug, galantamine (Reminyl\u0002), also potentiates nAChRs (66).",
      "key": "37775c5e63e92273ee7c44d6d344ddd0",
      "line": 443,
      "relation": "decreases",
      "source": 3,
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most commonly prescribed treatments for AD are acetylcholinesterase inhibitors, which decrease the hydrolysis rate of ACh and, thereby, enhance cholinergic signaling. One such drug, galantamine (Reminyl\u0002), also potentiates nAChRs (66).",
      "key": "1406ff181295323d5c9d645acbfa816d",
      "line": 444,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 3,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most commonly prescribed treatments for AD are acetylcholinesterase inhibitors, which decrease the hydrolysis rate of ACh and, thereby, enhance cholinergic signaling. One such drug, galantamine (Reminyl\u0002), also potentiates nAChRs (66).",
      "key": "05fa0a29a12306a3ff87ee72361993aa",
      "line": 445,
      "relation": "isA",
      "source": 17,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "The most commonly prescribed treatments for AD are acetylcholinesterase inhibitors, which decrease the hydrolysis rate of ACh and, thereby, enhance cholinergic signaling. One such drug, galantamine (Reminyl\u0002), also potentiates nAChRs (66).",
      "key": "26ce095ba72e53c97817e6bfd482a9a3",
      "line": 446,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 17,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Although Aβ peptides negatively alter the cholinergic system at multiple sites, including ACh synthesis, ACh release, and muscarinic receptors (157), the discovery that Aβ1−42 binds to α7 nAChRs with high afﬁnity suggested the potential for a causal role of nAChRs in AD (159, 160).",
      "key": "ae3410453d2f431ee1119af5bef1943e",
      "line": 457,
      "relation": "decreases",
      "source": 5,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Although Aβ peptides negatively alter the cholinergic system at multiple sites, including ACh synthesis, ACh release, and muscarinic receptors (157), the discovery that Aβ1−42 binds to α7 nAChRs with high afﬁnity suggested the potential for a causal role of nAChRs in AD (159, 160).",
      "key": "bbb4ae205c292c2cbb7bd11743f7a2cf",
      "line": 458,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 5,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Although Aβ peptides negatively alter the cholinergic system at multiple sites, including ACh synthesis, ACh release, and muscarinic receptors (157), the discovery that Aβ1−42 binds to α7 nAChRs with high afﬁnity suggested the potential for a causal role of nAChRs in AD (159, 160).",
      "key": "8660ab560fcf6ae58458d3047d234103",
      "line": 459,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 59
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "29e4ba453630a0494d74df054d47e8fd",
      "line": 469,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 65
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "fe2e2304b46137f8977aa98acd61ea86",
      "line": 471,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Although Aβ peptides negatively alter the cholinergic system at multiple sites, including ACh synthesis, ACh release, and muscarinic receptors (157), the discovery that Aβ1−42 binds to α7 nAChRs with high afﬁnity suggested the potential for a causal role of nAChRs in AD (159, 160).",
      "key": "a2b38575508437784151c3f1f838efdd",
      "line": 461,
      "relation": "association",
      "source": 51,
      "target": 72
    },
    {
      "key": "650799f91c4668a99a6f270c14302404",
      "relation": "partOf",
      "source": 4,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "78a2b1c50e42ddc32140691dac6b8a93",
      "line": 466,
      "relation": "association",
      "source": 24,
      "target": 65
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "6d94b241b395c3d04f872ba921b026b9",
      "line": 470,
      "relation": "positiveCorrelation",
      "source": 71,
      "target": 65
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "9a2c6872afee9972ecccec83d51e9c52",
      "line": 472,
      "relation": "positiveCorrelation",
      "source": 71,
      "target": 63
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 70,
      "target": 71
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "f017438237f8a8ce121e43aecfe3c441",
      "line": 471,
      "relation": "positiveCorrelation",
      "source": 63,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "This prospect was supported by the finding that α7 nAChRs were found in plaques (159), and α7 and α4 subunits positively correlated with neurons that accumulated Aβ and hyperphosphorylated tau in AD brain tissue (161).",
      "key": "efc9fd4a68082bdc2296b2d2012fe802",
      "line": 472,
      "relation": "positiveCorrelation",
      "source": 63,
      "target": 71
    },
    {
      "key": "7fdf743c97b6a78eaa1d0e48f5025dec",
      "relation": "hasVariant",
      "source": 63,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "A mutation in the gene encoding the α4 nAChR subunit (CHRNA4) causes a genetically transmissible form of epilepsy, which was the ﬁrst discovery of a human disease associated with a neuronal nAChR (165, 166). The mutation has been identiﬁed as a single base substitution converting a serine into threonine (S248F) in the TM2 domain of the α4 subunit (165).",
      "key": "a1379fd628334457120b6dae4dfd7156",
      "line": 480,
      "relation": "increases",
      "source": 64,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Subsequent to the original discovery, several other families suffering from typical ADNFLE or nocturnal frontal lobe epilepsy (NFLE) have been found to have a mutation either in α4 or β2 (encoded by CHRNB2) (165, 166, 168–170).",
      "key": "704ea57e043b524e7c29a37ab4f14113",
      "line": 485,
      "relation": "positiveCorrelation",
      "source": 56,
      "target": 74
    },
    {
      "key": "723f7b8b2fba7fd16c95b6c7efef68ef",
      "relation": "hasVariant",
      "source": 55,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Subsequent to the original discovery, several other families suffering from typical ADNFLE or nocturnal frontal lobe epilepsy (NFLE) have been found to have a mutation either in α4 or β2 (encoded by CHRNB2) (165, 166, 168–170).",
      "key": "e65ad6eb8b8d7844eace6f9368a30bfd",
      "line": 485,
      "relation": "positiveCorrelation",
      "source": 74,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Subsequent to the original discovery, several other families suffering from typical ADNFLE or nocturnal frontal lobe epilepsy (NFLE) have been found to have a mutation either in α4 or β2 (encoded by CHRNB2) (165, 166, 168–170).",
      "key": "fec73ca98301a2b4b197bef4de6c62e4",
      "line": 486,
      "relation": "positiveCorrelation",
      "source": 74,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bertrand D",
          "Dani JA"
        ],
        "date": "2007-01-01",
        "db": "PubMed",
        "db_id": "17009926",
        "db_name": "Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.",
        "first": "Dani JA",
        "journal": "Annual review of pharmacology and toxicology",
        "last": "Bertrand D",
        "pages": "699-729",
        "volume": "47"
      },
      "evidence": "Subsequent to the original discovery, several other families suffering from typical ADNFLE or nocturnal frontal lobe epilepsy (NFLE) have been found to have a mutation either in α4 or β2 (encoded by CHRNB2) (165, 166, 168–170).",
      "key": "6dac0b39261a1da52b88e3122785a1f8",
      "line": 486,
      "relation": "positiveCorrelation",
      "source": 58,
      "target": 74
    },
    {
      "key": "92c8f4718a2d6d0eaec4a516a270c894",
      "relation": "hasVariant",
      "source": 57,
      "target": 58
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"1,1-dimethyl-4-phenylpiperazinium iodide\")",
      "concept": {
        "name": "1,1-dimethyl-4-phenylpiperazinium iodide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "030b918b1150ea29dc7b0b039986e596"
    },
    {
      "bel": "a(CHEBI:\"1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methyl-3-isoxazolyl)urea\")",
      "concept": {
        "name": "1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methyl-3-isoxazolyl)urea",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "d20b83bb434c1f7a9010dfc565782d71"
    },
    {
      "bel": "a(CHEBI:\"5-hydroxyindole\")",
      "concept": {
        "name": "5-hydroxyindole",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3184b222c65b5616d1a7554e919a4e11"
    },
    {
      "bel": "a(CHEBI:\"EC 3.1.1.7 (acetylcholinesterase) inhibitor\")",
      "concept": {
        "name": "EC 3.1.1.7 (acetylcholinesterase) inhibitor",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "631f9b98d68ddd2885ac315ffcd9c0a4"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "concept": {
        "name": "amyloid-beta polypeptide 42",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ef705fbb8d4e7ba18fb04daf5d329b6b"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"dihydro-beta-erythroidine\")",
      "concept": {
        "name": "dihydro-beta-erythroidine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "09c112a79d6c1123f6f20f8b99fdf8c7"
    },
    {
      "bel": "a(CHEBI:\"gamma-aminobutyric acid\")",
      "concept": {
        "name": "gamma-aminobutyric acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "de151e035b8e17ac675ada95b66a6db6"
    },
    {
      "bel": "a(CHEBI:\"glutamate(2-)\")",
      "concept": {
        "name": "glutamate(2-)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f038ea8a4f75cf654709ad9030bee114"
    },
    {
      "bel": "a(CHEBI:\"nicotinic acetylcholine receptor agonist\")",
      "concept": {
        "name": "nicotinic acetylcholine receptor agonist",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "d317bb416a51f905e3f3f00e1b314992"
    },
    {
      "bel": "a(CHEBI:\"nicotinic antagonist\")",
      "concept": {
        "name": "nicotinic antagonist",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "037609bb4459580bc1def499efd6fc9c"
    },
    {
      "bel": "a(CHEBI:Mecamylamine)",
      "concept": {
        "name": "Mecamylamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "0a541fa62f153d4c8ae539050da2562d"
    },
    {
      "bel": "a(CHEBI:acetate)",
      "concept": {
        "name": "acetate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b946b926440b9042a4a9dff4ee9593ff"
    },
    {
      "bel": "a(CHEBI:acetylcholine)",
      "concept": {
        "name": "acetylcholine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ff868385e5c4b568faf7e1eaa79ba0c4"
    },
    {
      "bel": "a(CHEBI:choline)",
      "concept": {
        "name": "choline",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f12a351b5f9a78a66aaf4bb127dafc04"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "concept": {
        "name": "dopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4c950dc480c64069e58998401b2083c1"
    },
    {
      "bel": "a(CHEBI:galanthamine)",
      "concept": {
        "name": "galanthamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e801888eadb6e8f7cdcbdafe3172ef65"
    },
    {
      "bel": "a(CHEBI:genistein)",
      "concept": {
        "name": "genistein",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "53639bd1ad118846e01e79ec7bf1efd7"
    },
    {
      "bel": "a(CHEBI:ivermectin)",
      "concept": {
        "name": "ivermectin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e7e2811a9f58969ab6177a2bf9ecaad5"
    },
    {
      "bel": "a(CHEBI:nicotine)",
      "concept": {
        "name": "nicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "44ed555f78bacda2933ddef1d4280ce9"
    },
    {
      "bel": "a(CHEBI:noradrenaline)",
      "concept": {
        "name": "noradrenaline",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c56eb323f9e42a2756faee75d4e66595"
    },
    {
      "bel": "a(CHEBI:serotonin)",
      "concept": {
        "name": "serotonin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "257dd38b62d4d98c8f099144b931897e"
    },
    {
      "bel": "a(CHEBI:tetrodotoxin)",
      "concept": {
        "name": "tetrodotoxin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f83c27ddc8e563d5d07f6b45f6b3296c"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "cb9ddfdb593aa8073305b79828d71376"
    },
    {
      "bel": "a(MESH:\"Cations, Divalent\")",
      "concept": {
        "name": "Cations, Divalent",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "02072ee4d0bdb8c823f2c3d03fe06edf"
    },
    {
      "bel": "a(MESH:\"Cations, Monovalent\")",
      "concept": {
        "name": "Cations, Monovalent",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a35a818fa4b556c2697c55acc82ae170"
    },
    {
      "bel": "a(PUBCHEM:5311278)",
      "concept": {
        "name": "5311278",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "9027dd2bf38344f029e772a1c74f1358"
    },
    {
      "bel": "bp(GO:\"action potential\")",
      "concept": {
        "name": "action potential",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "acd5a7d036840a9554430f802627d266"
    },
    {
      "bel": "bp(GO:\"circadian sleep/wake cycle, REM sleep\")",
      "concept": {
        "name": "circadian sleep/wake cycle, REM sleep",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "da184c464a14ebc40e4f7a4f360405bd"
    },
    {
      "bel": "bp(GO:\"circadian sleep/wake cycle, wakefulness\")",
      "concept": {
        "name": "circadian sleep/wake cycle, wakefulness",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1217eb7cddb80dd0091b9323ad91c81b"
    },
    {
      "bel": "bp(GO:\"depolarization of postsynaptic membrane\")",
      "concept": {
        "name": "depolarization of postsynaptic membrane",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "881a3971d595152fb59681ac1a8c1f77"
    },
    {
      "bel": "bp(GO:\"developmental process\")",
      "concept": {
        "name": "developmental process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "bb1c00807cce50909e5dc81a8b482650"
    },
    {
      "bel": "bp(GO:\"long term synaptic depression\")",
      "concept": {
        "name": "long term synaptic depression",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "79d4e98409f1d0a85502d78710b5c430"
    },
    {
      "bel": "bp(GO:\"long-term synaptic potentiation\")",
      "concept": {
        "name": "long-term synaptic potentiation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ab5cdc5c0ef7a3c4b3461ab4dcfa6730"
    },
    {
      "bel": "bp(GO:\"membrane depolarization\")",
      "concept": {
        "name": "membrane depolarization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "aae614e2b00120b9a1dc849720fbd3cd"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"neuron remodeling\")",
      "concept": {
        "name": "neuron remodeling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "69ed037200b19011782f87305795d527"
    },
    {
      "bel": "bp(GO:\"neurotransmitter secretion\")",
      "concept": {
        "name": "neurotransmitter secretion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ec4b7a70780da73311c0a0f3ee438d8d"
    },
    {
      "bel": "bp(GO:\"regulation of action potential firing pattern\")",
      "concept": {
        "name": "regulation of action potential firing pattern",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "0681e115e4484cfe7ccc6b847a558e89"
    },
    {
      "bel": "bp(GO:\"regulation of action potential firing rate\")",
      "concept": {
        "name": "regulation of action potential firing rate",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "152bd9dd7d1f3ba6dbd683200c52dba8"
    },
    {
      "bel": "bp(GO:\"regulation of synaptic plasticity\")",
      "concept": {
        "name": "regulation of synaptic plasticity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "03639a6f8b863bc0519adc6ebb4bab7d"
    },
    {
      "bel": "bp(GO:\"response to pain\")",
      "concept": {
        "name": "response to pain",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8a1fa2742ddd5fe4fc4bb102cfeec455"
    },
    {
      "bel": "bp(GO:\"rhythmic excitation\")",
      "concept": {
        "name": "rhythmic excitation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8eae442d04b9da53670df677a21fc90a"
    },
    {
      "bel": "bp(GO:\"synaptic transmission, cholinergic\")",
      "concept": {
        "name": "synaptic transmission, cholinergic",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c54cecac2ccda49552ddbed1a652f5b9"
    },
    {
      "bel": "bp(GO:\"synaptic transmission, glutamatergic\")",
      "concept": {
        "name": "synaptic transmission, glutamatergic",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5877395a7b5611ac3adf769c874bf33b"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(GO:learning)",
      "concept": {
        "name": "learning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "75fc4f4e732353b87f83a4a8174ffb29"
    },
    {
      "bel": "bp(GO:memory)",
      "concept": {
        "name": "memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e03a718b44a1ff30acea5c31966879a9"
    },
    {
      "bel": "complex(GO:\"GABA-A receptor complex\")",
      "concept": {
        "name": "GABA-A receptor complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "af9cec13accfd4deca0f8de7b75abfbe"
    },
    {
      "bel": "complex(GO:\"voltage-gated calcium channel complex\")",
      "concept": {
        "name": "voltage-gated calcium channel complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "16c268293346ab34dbeb93833fc4d0d1"
    },
    {
      "bel": "complex(a(CHEBI:\"amyloid-beta polypeptide 42\"), p(HGNC:CHRNA7))",
      "function": "Complex",
      "id": "7734aae9bbbfdd462598c822b5ecab61",
      "members": [
        {
          "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
          "concept": {
            "name": "amyloid-beta polypeptide 42",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "ef705fbb8d4e7ba18fb04daf5d329b6b"
        },
        {
          "bel": "p(HGNC:CHRNA7)",
          "concept": {
            "name": "CHRNA7",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9bc1722fb5ef96f07f754ae7740789e2"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"1,1-dimethyl-4-phenylpiperazinium iodide\"), a(CHEBI:ivermectin))",
      "function": "Composite",
      "id": "889cc1ee0467ab31b14e68a8ef82ead8",
      "members": [
        {
          "bel": "a(CHEBI:\"1,1-dimethyl-4-phenylpiperazinium iodide\")",
          "concept": {
            "name": "1,1-dimethyl-4-phenylpiperazinium iodide",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "030b918b1150ea29dc7b0b039986e596"
        },
        {
          "bel": "a(CHEBI:ivermectin)",
          "concept": {
            "name": "ivermectin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "e7e2811a9f58969ab6177a2bf9ecaad5"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"5-hydroxyindole\"), a(CHEBI:acetylcholine))",
      "function": "Composite",
      "id": "bcb8765d0d51b5ce8f9d782113ea723a",
      "members": [
        {
          "bel": "a(CHEBI:\"5-hydroxyindole\")",
          "concept": {
            "name": "5-hydroxyindole",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "3184b222c65b5616d1a7554e919a4e11"
        },
        {
          "bel": "a(CHEBI:acetylcholine)",
          "concept": {
            "name": "acetylcholine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "ff868385e5c4b568faf7e1eaa79ba0c4"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:acetylcholine), a(CHEBI:ivermectin))",
      "function": "Composite",
      "id": "dc8fcb47d1a83b6754079d2bb105d0a2",
      "members": [
        {
          "bel": "a(CHEBI:acetylcholine)",
          "concept": {
            "name": "acetylcholine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "ff868385e5c4b568faf7e1eaa79ba0c4"
        },
        {
          "bel": "a(CHEBI:ivermectin)",
          "concept": {
            "name": "ivermectin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "e7e2811a9f58969ab6177a2bf9ecaad5"
        }
      ]
    },
    {
      "bel": "g(HGNC:CHRNA4)",
      "concept": {
        "name": "CHRNA4",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "da3d0cd5d54c2080423327350e5a1357"
    },
    {
      "bel": "g(HGNC:CHRNA4, var(\"?\"))",
      "concept": {
        "name": "CHRNA4",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "e86c599ee7b661d0866a29ecd3f2f039",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "g(HGNC:CHRNB2)",
      "concept": {
        "name": "CHRNB2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "c4a2990d4d0a776a9f3647dc7161045c"
    },
    {
      "bel": "g(HGNC:CHRNB2, var(\"?\"))",
      "concept": {
        "name": "CHRNB2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "bb25787c2c50e6aef346166430453476",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(FPLX:CHRM)",
      "concept": {
        "name": "CHRM",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "c3d6bfb7407189e52cb49026ccd5bee4"
    },
    {
      "bel": "p(FPLX:CHRN)",
      "concept": {
        "name": "CHRN",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "83ec6f28701674367e6d6be212520d7d"
    },
    {
      "bel": "p(FPLX:SRC)",
      "concept": {
        "name": "SRC",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "0c7e39abb4ebb288d2427514c7795c54"
    },
    {
      "bel": "p(HGNC:ACHE)",
      "concept": {
        "name": "ACHE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d4b209d60c245bf738c274ea16eaac1b"
    },
    {
      "bel": "p(HGNC:CHRNA4)",
      "concept": {
        "name": "CHRNA4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "80f72d8d35ebd95851a4fbebf17fce4b"
    },
    {
      "bel": "p(HGNC:CHRNA4, var(\"p.Ser248Thr\"))",
      "concept": {
        "name": "CHRNA4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3c97ecf399b8fc8f97d5653525a5fd31",
      "variants": [
        {
          "hgvs": "p.Ser248Thr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:CHRNA7)",
      "concept": {
        "name": "CHRNA7",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9bc1722fb5ef96f07f754ae7740789e2"
    },
    {
      "bel": "p(HGNC:CHRNA7, pmod(Ph))",
      "concept": {
        "name": "CHRNA7",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e1561368602de53fd3dbe8969175876f",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:CHRNA7, var(\"p.Leu254Thr\"))",
      "concept": {
        "name": "CHRNA7",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d54d09f9c646ad1ac6577584ba5a433",
      "variants": [
        {
          "hgvs": "p.Leu254Thr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:CHRNA7, var(\"p.Leu255Thr\"))",
      "concept": {
        "name": "CHRNA7",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cecfc02f0b5a018c52d7155ff42f0e90",
      "variants": [
        {
          "hgvs": "p.Leu255Thr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:CHRNB2)",
      "concept": {
        "name": "CHRNB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7e5d65d97e555667e0928696d86663e6"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Autistic Disorder\")",
      "concept": {
        "name": "Autistic Disorder",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "3d45405269a0fa6c7213af16dac89766"
    },
    {
      "bel": "path(MESH:\"Autosomal Dominant Nocturnal Frontal Lobe Epilepsy\")",
      "concept": {
        "name": "Autosomal Dominant Nocturnal Frontal Lobe Epilepsy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ef844f9d873907c1c3c913221a6bb0e0"
    },
    {
      "bel": "path(MESH:\"Behavior, Addictive\")",
      "concept": {
        "name": "Behavior, Addictive",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "591ce7dffbbd2b437e2cca6c2e68a202"
    },
    {
      "bel": "path(MESH:\"Down Syndrome\")",
      "concept": {
        "name": "Down Syndrome",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4b9d346d5e19e3224a1157409ce16510"
    },
    {
      "bel": "path(MESH:\"Lewy Body Disease\")",
      "concept": {
        "name": "Lewy Body Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a7168678b41ade6ae6c13573a8c9a4e6"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "concept": {
        "name": "Parkinson Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e45482025720b7db29c4fea458b4cae9"
    },
    {
      "bel": "path(MESH:Anxiety)",
      "concept": {
        "name": "Anxiety",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "81296be1c4ea6bcc3d464a0a9d9342b0"
    },
    {
      "bel": "path(MESH:Arousal)",
      "concept": {
        "name": "Arousal",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "32a929cb1da8e57a3df79e4ee1807d9c"
    },
    {
      "bel": "path(MESH:Attention)",
      "concept": {
        "name": "Attention",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f22e7196f5d0614ad79325e3690466ec"
    },
    {
      "bel": "path(MESH:Depression)",
      "concept": {
        "name": "Depression",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4cbb9f9f3c1f12c3f20dc0eb627a8224"
    },
    {
      "bel": "path(MESH:Epilepsy)",
      "concept": {
        "name": "Epilepsy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e790b858a85cda26640b78aeb308fe68"
    },
    {
      "bel": "path(MESH:Schizophrenia)",
      "concept": {
        "name": "Schizophrenia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "af624e8cd364532e7f498f047527caac"
    },
    {
      "bel": "rxn(reactants(a(CHEBI:acetylcholine)), products(a(CHEBI:acetate), a(CHEBI:choline)))",
      "function": "Reaction",
      "id": "12dfd372ce5328cd3e61c6c32c9f4994",
      "products": [
        {
          "bel": "a(CHEBI:acetate)",
          "concept": {
            "name": "acetate",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "b946b926440b9042a4a9dff4ee9593ff"
        },
        {
          "bel": "a(CHEBI:choline)",
          "concept": {
            "name": "choline",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "f12a351b5f9a78a66aaf4bb127dafc04"
        }
      ],
      "reactants": [
        {
          "bel": "a(CHEBI:acetylcholine)",
          "concept": {
            "name": "acetylcholine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "ff868385e5c4b568faf7e1eaa79ba0c4"
        }
      ]
    }
  ]
}